Immunotherapy Company PDS Biotechnology Strengthens Senior Management Team,...
NORTH BRUNSWICK, N.J., Jan. 20, 2016 /PRNewswire/ -- PDS Biotechnology, a clinical-stage biotechnology company developing cancer immunotherapies, is pleased to announce the appointments of Dr. Robert...
View ArticleInova Embraces Obama Administration "Moonshot" to Cure Cancer Initiative by...
FALLS CHURCH, Va., Jan. 21, 2016 /PRNewswire-USNewswire/ -- At last week's State of the Union address, President Obama brought renewed resolve to the fight to cure cancer, acknowledging that the...
View ArticleThe Molecular Diagnostics Reports Bundle includes the following TriMark...
NEW YORK, Jan. 21, 2016 /PRNewswire/ -- Below are summaries of each report, along with a link to download a product sample which includes: detailed table of contents, writer's background, executive...
View ArticleGuided Therapeutics Expects Significant Sales Growth in 2016
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company expects to achieve a second...
View ArticleAmgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For...
THOUSAND OAKS, Calif., Jan. 21, 2016 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication...
View ArticleCellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of...
BEVERLY, MA--(Marketwired - January 22, 2016) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
View ArticleEmergent BioSolutions Announces Executive Management Team of New Spin-Off...
(Source: Emergent BioSolutions Inc) , (GLOBE NEWSWIRE) -- (NYSE:EBS) today announced the anticipated executive management team of , Emergent's planned Biosciences business spin-off company. Members of...
View ArticleAmgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For...
THOUSAND OAKS, Calif., Jan. 21, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication...
View ArticleEmergent BioSolutions Announces Executive Management Team of New Spin-Off...
GAITHERSBURG, Md., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the anticipated executive management team of Aptevo Therapeutics Inc., Emergent’s planned...
View ArticleAmgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For...
(Source: Amgen Inc) , /PRNewswire/ -- (NASDAQ:AMGN) today announced that the has approved the cholesterol-lowering medication Repatha (evolocumab) Injection, the first proprotein convertase...
View ArticleAsterias Biotherapeutics Announces Completion of Transfer of AST-VAC2...
(Source: BioTime Inc) , /PRNewswire/ -- (NYSE MKT: AST), announced that it has completed the transfer of its manufacturing processes to produce AST-VAC2 to . AST-VAC2 is an innovative immunotherapy...
View ArticleAllan L. Shaw Joins Syndax Pharmaceuticals as Chief Financial Officer (Syndax...
(Source: Syndax Pharmaceuticals Inc) . FOR IMMEDIATE RELEASE ALLAN L. SHAW JOINS SYNDAX PHARMACEUTICALS AS CHIEF FINANCIAL OFFICER WALTHAM, Mass., January 20, 2016 - Syndax Pharmaceuticals, Inc., a...
View ArticleAsterias Biotherapeutics Announces Completion of Transfer of AST-VAC2...
FREMONT, Calif., Jan. 21, 2016 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), announced that it has completed the transfer of its manufacturing processes to produce AST-VAC2 to Cancer...
View Article3 Stocks Tackling Concussion Issues in Pro Athletes
REDONDO BEACH, CA / ACCESSWIRE / January 20, 2016 / The 2015 drama Concussion starring Will Smith follows the story of Dr. Bennet Omalu's battle with the National Football League to acknowledge...
View ArticleREPATHA® (EVOLOCUMAB) APPROVED AS FIRST PCSK9 INHIBITOR IN JAPAN FOR THE...
(Source: Astellas Pharma Inc) Repatha Japan Approval Press Release News Release REPATHA® (EVOLOCUMAB) APPROVED AS FIRST PCSK9 INHIBITOR IN JAPAN FOR THE TREATMENT OF HIGH CHOLESTEROL Important...
View ArticleTwo Conferences Invite LIMR Researcher to Discuss Her Groundbreaking...
(Source: MLH - Main Line Health Inc) (Wynnewood, Pa.) - Laura Mandik-Nayak, PhD, Associate Professor at the Lankenau Institute for Medical Research (LIMR), was invited to speak at two conferences in...
View ArticleAllan L. Shaw Joins Syndax Pharmaceuticals As Chief Financial Officer
WALTHAM, Mass., Jan. 20, 2016 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing entinostat in multiple cancer indications, announced today...
View ArticlePhilogen Announces Exercise of Options Within the License Agreement With...
SIENA, Italy, January 21, 2016 /PRNewswire/ -- Philogen S.p.A., today announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014 for the...
View ArticleSingularity University and BD Announce Collaboration Dedicated to Address...
MOUNTAIN VIEW, Calif. and FRANKLIN LAKES, N.J., Jan. 21, 2016 /PRNewswire/ -- Singularity University (SU), a benefit corporation focused on empowering leaders to leverage exponentially growing...
View ArticleOptum and PAREXEL to Accelerate Drug Development, Reimbursement and Market...
(Source: UnitedHealth Group Inc) Optum and PAREXEL International (NASDAQ:PRXL) formed a strategic alliance to reduce drug development costs associated with post-approval studies, which are conducted...
View Article
